greenlight biosciences is a privately-held biotechnology company focused on sustainable production of chemicals and fuels using its patented cell free bioprocessing technology platform. this revolutionary technology enables the biological conversion of economical, renewable substrates to valuable products with unprecedented flexibility and control.
Company profile
Ticker
GRNA
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Environmental Impact Acquisition Corp
SEC CIK
Corporate docs
Subsidiaries
GreenLight Biosciences Holdings • GreenLight Security Corporation • GreenLight Biosciences Espana, S.L. ...
IRS number
851914700
GRNA stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
11 Aug 23
8-K/A
GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares
28 Jul 23
EFFECT
Notice of effectiveness
26 Jul 23
EFFECT
Notice of effectiveness
26 Jul 23
POS AM
Prospectus update (post-effective amendment)
24 Jul 23
POS AM
Prospectus update (post-effective amendment)
24 Jul 23
S-8 POS
Registration of securities for employees (post-effective amendment)
24 Jul 23
25-NSE
Exchange delisting
24 Jul 23
8-K
GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares
24 Jul 23
SC 13E3/A
Going private transaction (amended)
20 Jul 23
Latest ownership filings
SC 13D/A
Boscolo Intervest Ltd
28 Jul 23
SC 13D/A
Insud Pharma S.L.
28 Jul 23
SC 13D/A
Builders Vision, LLC
27 Jul 23
4
Change in insider ownership
27 Jul 23
3
Initial statement of insider ownership
27 Jul 23
4
Dennis A. Clarke
27 Jul 23
4
Eric Senior Anderson
27 Jul 23
4
Change in insider ownership
27 Jul 23
SC 13D/A
KODIAK VENTURE PARTNERS III LP
26 Jul 23
4
CHARLES L COONEY
26 Jul 23
Financial summary
Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 33.76 mm | 33.76 mm | 33.76 mm | 33.76 mm | 33.76 mm | 33.76 mm |
Cash burn (monthly) | 11.89 mm | 4.23 mm | 9.43 mm | 13.02 mm | 10.35 mm | 9.86 mm |
Cash used (since last report) | 153.02 mm | 54.48 mm | 121.41 mm | 167.65 mm | 133.29 mm | 126.90 mm |
Cash remaining | -119.26 mm | -20.72 mm | -87.65 mm | -133.89 mm | -99.53 mm | -93.14 mm |
Runway (months of cash) | -10.0 | -4.9 | -9.3 | -10.3 | -9.6 | -9.4 |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 86 |
Opened positions | 66 |
Closed positions | 4 |
Increased positions | 6 |
Reduced positions | 3 |
13F shares | Current |
---|---|
Total value | 7.82 bn |
Total shares | 160.21 mm |
Total puts | 0.00 |
Total calls | 117.50 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
S2G Advisors | 22.35 mm | $0.00 |
Lewis & Clark Ventures I | 18.17 mm | $0.00 |
Morningside Venture Investments | 16.92 mm | $0.00 |
Fall Line Endurance Fund | 11.45 mm | $3.30 mm |
Kodiak Venture Partners Iii | 9.81 mm | $0.00 |
Cormorant Asset Management | 9.19 mm | $2.74 bn |
Cormorant Global Healthcare Master Fund | 9.19 mm | $0.00 |
Fall Line Endurance GP | 8.90 mm | $0.00 |
Continental Grain | 6.49 mm | $1.95 bn |
MLS Capital Fund II | 5.82 mm | $0.00 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
24 Jul 23 | Xeraya Cove | Common Stock | Other | Dispose J | Yes | No | 0 | 1,734,277 | 0.00 | 0 |
24 Jul 23 | Morningside Venture Investments | Common Stock | Other | Dispose J | No | No | 0 | 16,919,155 | 0.00 | 0 |
24 Jul 23 | Roger David Richard | Common Stock, par value $0.0001 per share | Other | Dispose J | No | No | 0 | 69,888 | 0.00 | - |
24 Jul 23 | Series Greenlight, a separate series of BlueIO Growth | Common Stock, par value $0.0001 per share | Other | Dispose J | No | No | 0 | 500,890 | 0.00 | 0 |
24 Jul 23 | Series Greenlight 2, a separate series of BlueIO Growth | Common Stock, par value $0.0001 per share | Other | Acquire J | No | No | 0 | 569,423 | 0.00 | 0 |